BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23558567)

  • 1. K5/K14-positive cells contribute to salivary gland-like breast tumors with myoepithelial differentiation.
    Boecker W; Stenman G; Loening T; Andersson MK; Bankfalvi A; von Holstein S; Heegaard S; Lange A; Berg T; Samoilova V; Tiemann K; Buchwalow I
    Mod Pathol; 2013 Aug; 26(8):1086-100. PubMed ID: 23558567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells.
    Boecker W; Stenman G; Loening T; Andersson MK; Berg T; Lange A; Bankfalvi A; Samoilova V; Tiemann K; Buchwalow I
    Virchows Arch; 2015 Jan; 466(1):21-36. PubMed ID: 25344874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin is a novel myoepithelial cell marker in pleomorphic adenoma and other salivary gland tumors with myoepithelial differentiation.
    Tsuneki M; Maruyama S; Yamazaki M; Essa A; Abé T; Babkair HA; Ahsan MS; Cheng J; Saku T
    Virchows Arch; 2013 Mar; 462(3):297-305. PubMed ID: 23262786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myoepithelial differentiation markers in salivary gland neoplasia].
    Scarpellini F; Marucci G; Foschini MP
    Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
    Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
    Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma ex pleomorphic adenoma of minor salivary glands with major epithelial-myoepithelial component: clinicopathologic and immunohistochemical study of 3 cases.
    Sedassari BT; Dos Santos HT; Mariano FV; da Silva Lascane NA; Altemani A; Sousa S
    Ann Diagn Pathol; 2015 Jun; 19(3):164-8. PubMed ID: 25890488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoepithelial cell markers in salivary gland neoplasms.
    Furuse C; Sousa SO; Nunes FD; Magalhães MH; Araújo VC
    Int J Surg Pathol; 2005 Jan; 13(1):57-65. PubMed ID: 15735856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
    Prasad AR; Savera AT; Gown AM; Zarbo RJ
    Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vimentin as a marker of myoepithelial cells in salivary gland tumors.
    de Araújo VC; de Araújo NS
    Eur Arch Otorhinolaryngol; 1990; 247(4):252-5. PubMed ID: 2165413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT1 as a myoepithelial marker: a comparative study of breast, cutaneous, and salivary gland lesions.
    Ng JKM; Li JJX; Lai BSW; Tsang JY; Chan AWS; Cheung CMT; Ip ECC; Tse GM
    Hum Pathol; 2023 May; 135():76-83. PubMed ID: 36739952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland-like tumours of the breast: surgical and molecular pathology.
    Pia-Foschini M; Reis-Filho JS; Eusebi V; Lakhani SR
    J Clin Pathol; 2003 Jul; 56(7):497-506. PubMed ID: 12835294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of immunohistochemistry to the diagnosis of salivary gland tumors.
    de Araújo VC; de Sousa SO; Carvalho YR; de Araújo NS
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):195-202. PubMed ID: 10981871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors.
    Huang JW; Ming Z; Shrestha P; Mori M; Ilg E; Schäfer BW; Heizmann CW
    J Oral Pathol Med; 1996 Nov; 25(10):547-55. PubMed ID: 8986967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and neoplastic myoepithelial cells in salivary glands: an immunohistochemical study.
    Morinaga S; Nakajima T; Shimosato Y
    Hum Pathol; 1987 Dec; 18(12):1218-26. PubMed ID: 2824327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Salivary gland-like tumors of the breast].
    Otterbach F; Schmid KW
    Pathologe; 2006 Sep; 27(5):363-72. PubMed ID: 16896677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WT1 expression in salivary gland pleomorphic adenomas: a reliable marker of the neoplastic myoepithelium.
    Langman G; Andrews CL; Weissferdt A
    Mod Pathol; 2011 Feb; 24(2):168-74. PubMed ID: 21057459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thomsen-Friedenreich (T) antigen as marker of myoepithelial and basal cells in the parotid gland, pleomorphic adenomas and adenoid cystic carcinomas. An immunohistological comparison between T and sialosyl-T antigens, alpha-smooth muscle actin and cytokeratin 14.
    Therkildsen MH; Mandel U; Christensen M; Dabelsteen E
    APMIS; 1995; 103(7-8):558-67. PubMed ID: 7576573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of alpha vascular smooth-muscle actin in salivary gland tumors.
    Hirano T; Gluckman JL; deVries EJ
    Arch Otolaryngol Head Neck Surg; 1990 Jun; 116(6):692-6. PubMed ID: 1692711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.